Prime Capital Investment Advisors LLC Has $203,000 Stock Position in Xylem Inc. $XYL

Prime Capital Investment Advisors LLC lowered its stake in Xylem Inc. (NYSE:XYL) by 64.7% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 1,569 shares of the industrial products company’s stock after selling 2,873 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Xylem were worth $203,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Xylem by 1.3% during the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after purchasing an additional 362,127 shares during the period. Swedbank AB lifted its holdings in shares of Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after purchasing an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after purchasing an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after purchasing an additional 3,239,203 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Xylem by 2.9% during the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after purchasing an additional 94,560 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Down 1.7%

XYL opened at $144.30 on Monday. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $151.16. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The company has a market cap of $35.12 billion, a P/E ratio of 37.48, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. The company has a fifty day moving average price of $143.08 and a two-hundred day moving average price of $130.45.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the previous year, the firm posted $1.09 earnings per share. The business’s revenue was up 6.1% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s payout ratio is 41.56%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Mizuho lifted their price target on shares of Xylem from $125.00 to $140.00 and gave the stock a “neutral” rating in a report on Friday, September 12th. Barclays began coverage on shares of Xylem in a research note on Friday, September 19th. They set an “overweight” rating and a $165.00 target price for the company. Wall Street Zen raised shares of Xylem from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Citigroup lifted their target price on shares of Xylem from $168.00 to $173.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, UBS Group lifted their target price on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a research note on Tuesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $154.67.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.27% of the company’s stock.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.